Congo (the)

in page functions
[French]
Congo
Total population (2017) 4,866,223
Birth cohort (2017) 170,683
Surviving Infants (surviving to 1 year per year, 2017) 163,190
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 33/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 45/1000
World Bank Index, IDA (2015) 3.00
Gross Nation Income (per capita US$, 2015) 2,540
Co-financing group (2018) Fully self-financing
No. of districts/territories (2016) 41

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Congo

Type of support

Approvals

2001-2022 (US$)
(29 May 2018)

Commitments

2001-2022 (US$)
(29 May 2018)

Disbursements

2000-2018 (US$)
(29 May 2018)

% Disbursed

(29 May 2018)
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $28,680,244 $28,715,383 $28,135,705
Graduation grant (GG) $377,671 $412,810 $377,671 100%
Health system strengthening (HSS 1) $5,199,999 $5,199,999 $5,199,999 100%
Immunisation services support (ISS) $1,665,000 $1,665,000 $1,665,000 100%
Injection Safety Devices (NVS) $79,000 $79,000 $101,777 129%
Injection safety support (INS) $224,534 $224,534 $224,534 100%
IPV (NVS) $906,707 $906,707 $575,069 63%
MR-Catch-up campaign (NVS) $746,000 $746,000 0%
Penta (NVS) $7,846,759 $7,846,759 $8,102,721 103%
Pneumo (NVS) $7,042,651 $7,042,651 $7,427,691 105%
Rotavirus (NVS) $1,627,250 $1,627,250 $1,662,146 102%
Tetra DTP-HepB (NVS) $827,822 $827,822 $827,822 100%
Vaccine Introduction Grant (VIG) $810,000 $810,000 $633,000 78%
Yellow Fever (NVS) $1,326,851 $1,326,851 $1,338,275 101%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Congo DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 73%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2010) 72.30%
Household survey: DTP3 coverage for female (2010) 71.40%
Household survey: Last DTP3 survey (2010) 72%
% districts achieving > 80% DTP3 coverage (2016) 29%
% districts achieving < 50% DTP3 coverage (2016) 10%
MCV WHO/UNICEF estimates (2016) 80%

Breakdown of support

Non-vaccine support Vaccine support
29% 71%
$8,100,204 $20,035,501

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Congo

07 June 2018

IPV DRC 2015

Gavi Board approves funding for inactivated poliovirus vaccine until 2020

Flexible support to Nigeria and post-transition countries also approved.

21 May 2018

Ebola DRC first shots prepared

Ebola vaccine to help tackle DRC outbreak

Vaccination begins in the Democratic Republic of the Congo.

19 May 2018

Ebola Q&A thumb

DR Congo Ebola outbreak response: Q&A with Gavi CEO Dr Seth Berkley

Gavi CEO Dr Seth Berkley answers questions about the planned deployment of Merck’s rVSV-ZEBOV vaccine to counter the ongoing Ebola outbreak in the north west of the Democratic Republic of the Congo (DRC).

close icon

modal window here